Skip to main content
Intended for healthcare professionals

Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. Average time from submission to first decision: 14 days View full journal description

This journal is a member of the Committee on Publication Ethics (COPE).

Browse by

Articles most recently published online for this journal.
Restricted access
Review article
First published  

Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea

  • Spencer H. Durham PharmD, FCCP, BCPS, BCIDP
  • Amanda K. McAllister PharmD
  • Elias B. Chahine PharmD, FCCP, FASCP, FFSHP, BCPS, BCIDP
Restricted access
Research article
First published  

Effect of Non-benzodiazepine Versus Benzodiazepine Sedation on Days Alive and Free of Mechanical Ventilation in the Surgical/Trauma Intensive Care Unit

  • Travis VanOtterloo PharmD
  • Kyllie Ryan-Hummel PharmD, BCCCP
  • Rebecca Attridge PharmD, MSc, BCCCP
  • Dana Foster PharmD, BCCCP
  • Susannah Nicholson MD, MS, FACS
  • Jacob Tondre BS
  • Savanna Pittman BS
  • Sarah Berman PharmD, BCCCP
Restricted access
Research article
First published  

Influence of Kidney Function Estimation Methods on Carboplatin Dosing and Clinical Outcomes

  • Omar El Khatib PharmD
  • Sara Zekery-Saad PharmD
  • Emna Abidi PhD
  • Ahmed Abdelaziz BPharm
  • Osama Abu Tabar BPharm, MS
  • Mohammed Ahmed BPharm
  • Anum Farooq BPharm
  • Wasim S. El Nekidy PharmD, BCPS, BCACP, BCIDP, FCCP
Open Access
Research article
First published  

Efficacy of Continuous Infusions of Furosemide-Albumin Compared With Bumetanide in Critically Ill Patients: A Retrospective Cohort Study

  • Sara Hussein PharmD
  • Hala Halawi PharmD, BCCCP
  • Mahmoud Sabawi PharmD, BCCCP
View onlinefirst articles View latest issues
Most read articles in this journal in the last 6 months.
Free access
Review article
First published  

A Systematic Approach to Understanding Acid-Base Disorders in the Critically Ill

  • Jeffrey F. Barletta BS, PharmD
  • Justin Muir PharmD, BCCCP
  • Judah Brown PharmD, BCCCP
  • Amy Dzierba PharmD, BCCCP
Free access
Editorial
First published  

Believing FDA’s Assurance of Quality Pharmaceutical Products Can Be Dangerous to Your Patients’ Health

  • C. Michael White Pharm.D., FCP, FCCP, FASHP
  • Lyla R. White BS Pharm
Free access
Research article
First published  

Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal

  • Katherine M. Kessel PharmD
  • Logan M. Olson PharmD, BCCCP
  • Derek A. Kruse MD
  • Elizabeth R. Lyden MS
  • Kelsey E. Whiston PharmD, BCCCP
  • Mindy M. Blodgett APRN
  • Alena A. Balasanova MD
Free access
Editorial
First published  

Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide “For Research Purposes”

  • Jordyn Belcourt BS Pharm
  • Priscilla Ly BS Pharm
  • C. Michael White PharmD, FCP, FCCP, FASHP
View all
Most cited articles published in this journal in the last 3 years. These statistics are updated weekly using data sourced exclusively from CrossRef.
Restricted access
Review article
First published  

Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis

  • Thu Minh Truong PharmD
  • Gaurav N. Pathak PharmD
  • Amit Singal
  • Viktoriia Taranto MD
  • Babar K. Rao MD
Restricted access
Review article
First published  

Resmetirom: The First Food and Drug Administration–Approved Medication for Nonalcoholic Steatohepatitis (NASH)

  • Erenie Guirguis PharmD, BCPS
  • John Dougherty MBA, PharmD, BCPS, CPh
  • Krisy Thornby PharmD, BCPS
  • Yasmin Grace PharmD
  • Keri Mack PharmD, BCACP
Restricted access
Review article
First published  

Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer

  • Alexa J. Luboff BS
  • David L. DeRemer PharmD, BCOP
Restricted access
Review article
First published  

Targeted Therapies for Previously “Undruggable” KRAS-Mutated Non–Small Cell Lung Cancer: A Review of Sotorasib and Adagrasib

  • Natalie Mausey
  • Zachery Halford PharmD, BCOP, BCPPS
View all
Articles with the highest Altmetric score from the last 3 months, indicating influence and impact.
View All

You might be interested in

Publish with us

Authors will enjoy:

  • Rigorous peer review of your research
  • Prompt publishing
  • Multidisciplinary audience
  • High visibility for global exposure
Submit Now

Information for Authors, Editors, and Reviewers

Sage supports authors, editors, and reviewers throughout all steps of the publishing process. Explore our resources:

Call for Editor

Sage announces the search for a new Editor-in-Chief of our journal, Annals of Pharmacotherapy (AOP). Click the button below to learn more.

Learn More

Call for Reviewers

Annals of Pharmacotherapy is looking for new, qualified reviewers. Click the button below for information on signing up.

Learn More

Congratulations to Milap Nahata!

Editor-in-Chief, Milap Nahata, has been chosen to receive the 2024 Remington Honor Medal in March 2024. Congratulations on receiving the highest honor in pharmacy!

Click the button below to read the full press release.

Read More

Sage discipline hubs

Explore the content from across our disciplines, including the latest journal articles, special issues, and related books and digital library content.
View More

Also from Sage